Latest News from Pro PG

Historical supply notice: This article relates to a previous medicine shortage or regulatory approval. Availability and regulatory status may have changed. Healthcare professionals should contact Pro Pharmaceuticals Group to confirm the current supply position. For current Australian shortage and supply information, see medicine shortages in Australia. Pro Pharmaceuticals Group has arranged for the supply of the following overseas registered Gemfibrozil products on a tempora

Historical supply notice: This article relates to a previous medicine shortage or regulatory approval. Availability and regulatory status may have changed. Healthcare professionals should contact Pro Pharmaceuticals Group to confirm the current supply position. For current Australian shortage and supply information, see medicine shortages in Australia. Pro Pharmaceuticals Group has arranged for the supply of the following overseas registered tocilizumab products on a temporar

Historical supply notice: This article relates to a previous medicine shortage or regulatory approval. Availability and regulatory status may have changed. Healthcare professionals should contact Pro Pharmaceuticals Group to confirm the current supply position. For current Australian shortage and supply information, see medicine shortages in Australia. Pro Pharmaceuticals Group has arranged for the supply of the following overseas registered tocilizumab products on a temporar

Historical supply notice: This article relates to a previous medicine shortage or regulatory approval. Availability and regulatory status may have changed. Healthcare professionals should contact Pro Pharmaceuticals Group to confirm the current supply position. For current Australian shortage and supply information, see medicine shortages in Australia. ​Pro Pharmaceuticals Group has received the Section 19A approval for supply of Imipramine 25mg Tablets until 30th June 2021.

Historical supply notice: This article relates to a previous medicine shortage or regulatory approval. Availability and regulatory status may have changed. Healthcare professionals should contact Pro Pharmaceuticals Group to confirm the current supply position. For current Australian shortage and supply information, see medicine shortages in Australia. Pro Pharmaceuticals Group has received the Section 19A approval for supply of Imipramine 10mg Tablets until 15th October 2021

Historical supply notice: This article relates to a previous medicine shortage or regulatory approval. Availability and regulatory status may have changed. Healthcare professionals should contact Pro Pharmaceuticals Group to confirm the current supply position. For current Australian shortage and supply information, see medicine shortages in Australia. ​Pro Pharmaceuticals Group has received the Section 19A approval for supply of Bleomycin Injection until January 31st 2020.

Pro PG will supply HPS Group selected Special Access Scheme (SAS) products until 31st July 2020. Pro PG is proud to align with HPS for the supply and will work with the individual sites to ensure SAS process is adhered to and products directly supplied Nationally in a timely manner. HPS Group are one of Australia’s leading providers of pharmacy services to private hospitals, cancer centres, and correctional facilities.